Klogenix

Developer of therapeutics for the treatment of age-related diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2019 language klogenix.com

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 157 times.

YearFilings
20203
20212
20233
20242

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon